• Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=16888811).
  

PubMed=16888811; DOI=10.1002/jcb.21073
Moneo V., Serelde B.G., Fominaya J.M., Martinez-Leal J.F., Blanco-Aparicio C., Romero L., Sanchez-Beato M., Cigudosa J.C., Tercero J.C., Piris M.A., Jimeno J.M., Carnero A.
Extreme sensitivity to Yondelis (Trabectedin, ET-743) in low passaged sarcoma cell lines correlates with mutated p53.
J. Cell. Biochem. 100:339-348(2007)

PubMed=17431109; DOI=10.1158/1535-7163.MCT-06-0729
Moneo V., Serelde B.G., Leal J.F.M., Blanco-Aparicio C., Diaz-Uriarte R., Aracil M., Tercero J.C., Jimeno J.M., Carnero A.
Levels of p27(kip1) determine Aplidin sensitivity.
Mol. Cancer Ther. 6:1310-1316(2007)

CLPUB00464
Moneo V.
Generation of cellular tools for preclinical validation of antitumor compounds.
Thesis PhD (2009); Universidad Autonoma de Madrid; Madrid; Spain

PubMed=24758355; DOI=10.1186/1471-2407-14-281; PMCID=PMC4023704
Moneo V., Serelde B.G., Blanco-Aparicio C., Diaz-Uriarte R., Aviles P., Santamaria G., Tercero J.C., Cuevas C., Carnero A.
Levels of active tyrosine kinase receptor determine the tumor response to Zalypsis.
BMC Cancer 14:281.1-281.10(2014)